ODYSSEY | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

106 results for “ODYSSEY”

Trials

View all 40 →

ODYSSEY (PENTA 20)

792 participants · First posted Oct 8, 2014

Diagnostic Odyssey Survey 2

336 participants · First posted Sep 20, 2018

Odyssey Evaluation in Post LASIK Patients

30 participants · First posted Dec 3, 2025

Drugs

TREG(Odyssey)

INNATE IMMUNE(Odyssey)

CELL CYCLE(Odyssey)

Organizations

Odyssey Therapeutics

MEDSUPPLY AUSTRALIA PTY LTD

Australia

Stereotaxis

United States

News

View all 58 →

Odyssey Therapeutics to Present at September Investor Conferences as It Advances Autoimmune Pipeline

Odyssey Therapeutics Files for $232 Million Nasdaq IPO to Advance Autoimmune Disease Pipeline

Odyssey Therapeutics Raises $213M Series D to Advance Autoimmune Disease Pipeline After Shelving IPO Plans

Page 1 of 11